These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8389191)
1. Finasteride: a slow-binding 5 alpha-reductase inhibitor. Faller B; Farley D; Nick H Biochemistry; 1993 Jun; 32(21):5705-10. PubMed ID: 8389191 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat. Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729 [TBL] [Abstract][Full Text] [Related]
3. Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. Thigpen AE; Russell DW J Biol Chem; 1992 Apr; 267(12):8577-83. PubMed ID: 1314830 [TBL] [Abstract][Full Text] [Related]
4. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects. Giudici D; Briatico G; Cominato C; Zaccheo T; Iehlè C; Nesi M; Panzeri A; di Salle E J Steroid Biochem Mol Biol; 1996 Jun; 58(3):299-305. PubMed ID: 8836165 [TBL] [Abstract][Full Text] [Related]
5. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478 [TBL] [Abstract][Full Text] [Related]
6. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition. Rhodes L; Primka RL; Berman C; Vergult G; Gabriel M; Pierre-Malice M; Gibelin B Prostate; 1993; 22(1):43-51. PubMed ID: 8381228 [TBL] [Abstract][Full Text] [Related]
7. Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase. George FW; Russell DW; Wilson JD Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8044-7. PubMed ID: 1654556 [TBL] [Abstract][Full Text] [Related]
8. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review. Imperato-McGinley J Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167 [TBL] [Abstract][Full Text] [Related]
9. 17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1. Tian G; Stuart JD; Moss ML; Domanico PL; Bramson HN; Patel IR; Kadwell SH; Overton LK; Kost TA; Mook RA Biochemistry; 1994 Mar; 33(8):2291-6. PubMed ID: 8117686 [TBL] [Abstract][Full Text] [Related]
10. Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids. Tian G; Haffner CD J Biol Chem; 2001 Jun; 276(24):21359-64. PubMed ID: 11279132 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. Makridakis N; Reichardt JK J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333 [TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of steroid 5 alpha-reductase of rat liver and prostate microsomes. Liang T; Cheung AH; Reynolds GF; Rasmusson GH J Biol Chem; 1985 Apr; 260(8):4890-5. PubMed ID: 3988737 [TBL] [Abstract][Full Text] [Related]
14. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen. Geller J J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965 [TBL] [Abstract][Full Text] [Related]
15. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804 [TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors. Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453 [TBL] [Abstract][Full Text] [Related]
17. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. Diani AR; Mulholland MJ; Shull KL; Kubicek MF; Johnson GA; Schostarez HJ; Brunden MN; Buhl AE J Clin Endocrinol Metab; 1992 Feb; 74(2):345-50. PubMed ID: 1309834 [TBL] [Abstract][Full Text] [Related]
18. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. Imperato-McGinley J; Shackleton C; Orlic S; Stoner E J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740 [TBL] [Abstract][Full Text] [Related]
19. Novel aromatase and 5 alpha-reductase inhibitors. Di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T; Buzzetti F; Nesi M; Panzeri A J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):289-94. PubMed ID: 8043491 [TBL] [Abstract][Full Text] [Related]
20. Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes. Thigpen AE; Cala KM; Russell DW J Biol Chem; 1993 Aug; 268(23):17404-12. PubMed ID: 8394341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]